[HTML][HTML] The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
N Goikoetxea-Usandizaga, M Bravo… - Hepatology, 2023 - journals.lww.com
Abstract Background and Aims: Alcohol-associated liver disease (ALD) accounts for 70% of
liver-related deaths in Europe, with no effective approved therapies. Although mitochondrial …
liver-related deaths in Europe, with no effective approved therapies. Although mitochondrial …
[引用][C] The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
N Goikoetxea-Usandizaga, M Bravo… - Hepatology …, 2023 - investigacion.usc.gal
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
N Goikoetxea-Usandizaga, M Bravo… - Hepatology …, 2023 - pubmed.ncbi.nlm.nih.gov
Background and aims Alcohol-associated liver disease (ALD) accounts for 70% of liver-
related deaths in Europe, with no effective approved therapies. Although mitochondrial …
related deaths in Europe, with no effective approved therapies. Although mitochondrial …
[引用][C] The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
N Goikoetxea-Usandizaga, M Bravo… - Hepatology …, 2023 - investiga.upo.es
BACKGROUND AND AIMS: Alcohol-associated liver disease (ALD) accounts for 70% of
liver-related deaths in Europe, with no effective approved therapies. Although mitochondrial …
liver-related deaths in Europe, with no effective approved therapies. Although mitochondrial …
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
N Goikoetxea-Usandizaga, M Bravo, L Egia-Mendikute… - 2023 - digital.csic.es
Background and Aims: Alcohol-associated liver disease (ALD) accounts for 70% of liver-
related deaths in Europe, with no effective approved therapies. Although mitochondrial …
related deaths in Europe, with no effective approved therapies. Although mitochondrial …
[PDF][PDF] The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
N Goikoetxea-Usandizaga, M Bravo, L Egia-Mendikute… - Hepatology, 2023 - core.ac.uk
Abstract Background and Aims: Alcohol-associated liver disease (ALD) accounts for 70% of
liver-related deaths in Europe, with no effective approved therapies. Although mitochondrial …
liver-related deaths in Europe, with no effective approved therapies. Although mitochondrial …
The outcome of boosting mitochondrial activity in alcoholic liver disease (ALD) is organ-dependent.
N Goikoetxea-Usandizaga, M Bravo… - Hepatology …, 2023 - europepmc.org
Alcoholic liver disease (ALD) accounts for 70% of liver-related deaths in Europe, with no
effective approved therapies. Although mitochondrial dysfunction is one of the earliest …
effective approved therapies. Although mitochondrial dysfunction is one of the earliest …
[HTML][HTML] The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
N Goikoetxea-Usandizaga, M Bravo… - Hepatology …, 2023 - ncbi.nlm.nih.gov
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
- PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
- PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
[PDF][PDF] The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
N Goikoetxea-Usandizaga, M Bravo, L Egia-Mendikute… - 2023 - researchgate.net
Abstract Background and Aims: Alcohol-associated liver disease (ALD) accounts for 70% of
liver-related deaths in Europe, with no effective approved therapies. Although mitochondrial …
liver-related deaths in Europe, with no effective approved therapies. Although mitochondrial …
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
N Goikoetxea-Usandizaga, M Bravo… - …, 2023 - ingentaconnect.com
Background and Aims: Alcohol-associated liver disease (ALD) accounts for 70% of liver-
related deaths in Europe, with no effective approved therapies. Although mitochondrial …
related deaths in Europe, with no effective approved therapies. Although mitochondrial …